Business & Finance
Gilead receives positive CHMP opinions for lenacapavir as first twice-yearly HIV prevention option in EU
25 July 2025 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it has received a positive opinion from the Committee for Medicinal Products for Human Use of the Eu...
Genomma Lab Internacional announces Q2 2025 results
24 July 2025 - Mexico-based pharmaceutical company Genomma Lab Internacional, S.A.B. de C.V. (BMV:LAB B) on Wednesday reported its financial results for the second quarter of 2025.Genomma's secon...
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
18 July 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) confirmed on Friday that it has completed its acquisition of Blueprint Medicines Corporation (NASDAQ:BPMC).This e...
Perrigo to divest Dermacosmetics business for up to EUR327m
15 July 2025 - Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of consumer self-care products, announced on Monday that it has signed an agreement with Kairos Bidco AB, an investmen...
CVS Health declares quarterly dividend USD0.665 per share
8 July 2025 - US healthcare company CVS Health Corporation (NYSE: CVS) announced on Monday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per ...
Lilly declares dividend of USD1.50 for Q3
24 June 2025 - On Monday the board of directors of US pharmaceutical company Eli Lilly and Company (NYSE:LLY) declared a dividend of USD1.50 per share of common stock for the third quarter of 2025.Thi...